Rheumatology (Oxford). 2022 Dec 19:keac689. doi: 10.1093/rheumatology/keac689. Online ahead of print.
NO ABSTRACT
PMID:36534825 | DOI:10.1093/rheumatology/keac689
Categories
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomised phase III trial
